Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Adv Biol Regul. 2015 Dec 19;61:17–24. doi: 10.1016/j.jbior.2015.11.011

Figure 5.

Figure 5

Binding mode of GIVA cPLA2 and GVIA iPLA2 inhibitors elucidated using MD simulations guided by DXMS data. (A) Pyrrophenone in GIVA cPLA2. (B) 2-Oxoamide in GIVA cPLA2. (C) PHFK in GVIA iPLA2. Adopted from references 25 and 61.